Pricing Log in Create free account

Bright Minds Biosciences Inc. (DRUG) vs Valneva SE Sponsored ADR (VALN)

Bright Minds Biosciences Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Bright Minds Biosciences Inc. and Valneva SE Sponsored ADR are of similar size ($560.4M and $534.7M). Bright Minds Biosciences Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.7×. Bright Minds Biosciences Inc. has the higher net margin (0.00% vs −12.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Bright Minds Biosciences Inc. leads on 6 and Valneva SE Sponsored ADR on 6.

Valuation

Metric DRUG VALN Biotechnology median
P/E n/m 59.68 8.50
P/S n/m 3.05 9.71
P/B 2.27 5.30 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 42.91 0.64
EV/Sales n/m 3.49 9.21
Earnings yield (4.05%) 1.68% (33.15%)
Free cash flow yield (3.52%) (11.78%) (25.50%)

Profitability

Metric DRUG VALN Biotechnology median
Gross margin 0.00% 38.28% 65.16%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (13.64%) 0.00% (56.36%)
Return on assets (13.52%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DRUG VALN Biotechnology median
Revenue growth (TTM) — (53.16%) 6.02%
EPS growth (last fiscal year) (164.58%) (805.88%) 30.26%
Revenue growth, 5-year CAGR — 9.41% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRUG VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 121.98 2.16 4.72
Net debt to EBITDA 5.98 (1.15) 0.96

Dividend

Metric DRUG VALN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRUG VALN Biotechnology median
Market cap 534.73m 560.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack